126 related articles for article (PubMed ID: 3074762)
1. Peripheral blood lymphocyte subsets and natural killer cell number and function during alpha-interferon treatment for hairy cell leukemia.
Gibson J; Gallagher K; Cameron K; Basten A; Gatenby P; Joshua D; Kronenberg H
Aust N Z J Med; 1988 Dec; 18(7):897-9. PubMed ID: 3074762
[No Abstract] [Full Text] [Related]
2. Successful use of interferon alfa-n1 in the treatment of hairy cell leukemia.
Cawley JC; Bottomley JM; Worman CP
Med Clin North Am; 1986 May; Suppl():37-9. PubMed ID: 3488481
[TBL] [Abstract][Full Text] [Related]
3. Alpha-interferon activates the natural killer system in patients with hairy cell leukemia.
Semenzato G; Pizzolo G; Agostini C; Ambrosetti A; Zambello R; Trentin L; Luca M; Masciarelli M; Chilosi M; Vinante F
Blood; 1986 Jul; 68(1):293-6. PubMed ID: 3719101
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of T-hairy cell leukemia with lymphoblastoid-interferon.
Rossi E; Gualandi F; Lamparelli T; Repetto M; Nocera A; Spriano M; Occhini D; Ruggeri C; Vimercati R; Damasio EE
J Exp Pathol; 1987; 3(4):593-601. PubMed ID: 3502652
[No Abstract] [Full Text] [Related]
5. Strategy for the treatment of hairy cell leukemia.
Porzsolt F; Raghavachar A; Digel W; Raghavachar A; Bartram CR; Heimpel H
Leukemia; 1987 Apr; 1(4):334-7. PubMed ID: 3669758
[TBL] [Abstract][Full Text] [Related]
6. Effect of alpha-interferon on the immune system of patients with hairy cell leukemia.
Foa R; Fierro MT; Lusso P; Bonferroni M; Raspadori D; Buzzi M; Zinzani PL; Resegotti L; Lauria F
Leukemia; 1987 Apr; 1(4):377-9. PubMed ID: 3499543
[TBL] [Abstract][Full Text] [Related]
7. [Interferon in the treatment of hairy cell leukemia].
Deptała A
Acta Haematol Pol; 1989; 20(1):86-92. PubMed ID: 2515708
[No Abstract] [Full Text] [Related]
8. The beneficial effects of alpha-interferon in hairy cell leukemia are not attributable to NK cell-mediated cytotoxicity.
Griffiths SD; Cawley JC
Leukemia; 1987 Apr; 1(4):372-6. PubMed ID: 3669763
[TBL] [Abstract][Full Text] [Related]
9. Hematologic and immunologic changes in hairy cell leukemia patients treated with alpha interferon.
Turhan AG; Eaves CJ; Connors JM; Eaves AC; Karim KA; Silver KB
J Biol Regul Homeost Agents; 1988; 2(4):157-65. PubMed ID: 2907963
[TBL] [Abstract][Full Text] [Related]
10. Studies on the optimal dose and the mode of action of alpha-interferon in the treatment of hairy cell leukemia.
Huber C; Aulitzky W; Tilg H; von Lüttichau I; Troppmair J; Nachbauer K; Gastl G
Leukemia; 1987 Apr; 1(4):355-7. PubMed ID: 3669762
[TBL] [Abstract][Full Text] [Related]
11. Interferon alpha-2 for hairy cell leukemia: evidence for induction of RNA synthesis in hairy cells and failure to correlate enhancement of natural killer cells with elimination of hairy cells.
Schwarzmeier JD; Schwabe M; Prischl F; Wagner L; Lion T; Micksche M; Köller U
Eur J Haematol; 1987 Nov; 39(5):418-25. PubMed ID: 3691760
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of the increase in serine esterase-positive T cells in hairy-cell leukemia patients undergoing alpha-interferon therapy.
Wagner L; Goldstone AH; Worman CP
Leukemia; 1989 May; 3(5):373-9. PubMed ID: 2497282
[TBL] [Abstract][Full Text] [Related]
13. Alpha-interferon in hairy cell leukaemia: direct effects on hairy cells or indirect cytotoxicity?
Sigaux F; Castaigne S; Lehn P; Dupuy E; Billard C; Gluckman JC; Boiron M; Falcoff E; Flandrin G; Degos L
Int J Cancer Suppl; 1987; 1():2-8. PubMed ID: 3476473
[TBL] [Abstract][Full Text] [Related]
14. Durable complete remissions after 2'-deoxycoformycin treatment in patients with hairy cell leukemia resistant to interferon alpha.
Blick M; Lepe-Zuniga JL; Doig R; Quesada JR
Am J Hematol; 1990 Mar; 33(3):205-9. PubMed ID: 2301379
[TBL] [Abstract][Full Text] [Related]
15. Alpha-interferon induces remission in hairy cell leukemia without enhancement of natural killing.
Gastl G; Aulitzky W; Leiter E; Flener R; Huber C
Blut; 1986 May; 52(5):273-9. PubMed ID: 3635416
[TBL] [Abstract][Full Text] [Related]
16. Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity.
Chilosi M; Semenzato G; Cetto G; Ambrosetti A; Fiore-Donati L; Perona G; Berton G; Lestani M; Scarpa A; Agostini C
Blood; 1987 Nov; 70(5):1530-5. PubMed ID: 3117133
[TBL] [Abstract][Full Text] [Related]
17. Immunological recovery and dose evaluation in IFN-alpha treatment of hairy cell leukemia: analysis of leukocyte differentiation antigens, NK and 2',5'-oligoadenylate synthetase activity.
Nielsen B; Hokland M; Justesen J; Hasselbalch H; Ellegaard J; Hokland P
Eur J Haematol; 1989 Jan; 42(1):50-9. PubMed ID: 2914594
[TBL] [Abstract][Full Text] [Related]
18. Alpha-interferon and lymphokine-activated killer cells in hairy cell leukemia.
Griffiths SD; Cawley JC
Leukemia; 1988 Jun; 2(6):377-81. PubMed ID: 3374170
[TBL] [Abstract][Full Text] [Related]
19. Hairy-cells are not lysed by NK-cells.
Sigaux F; Chapuis F; Castaigne S; Degos L; Flandrin G; Gluckman JC
Blut; 1987 May; 54(5):319-20. PubMed ID: 3567370
[No Abstract] [Full Text] [Related]
20. [Hairy-cell leukemia as a model for studying the effects of interferon on the immune system].
Semenzato G; Trentin L; Bulian P; Agostini C; Chisesi T; Pizzolo G
Haematologica; 1990; 75 Suppl 4():10-9. PubMed ID: 1705910
[No Abstract] [Full Text] [Related]
[Next] [New Search]
